Key Takeaways
- • German start-ups raised EUR 3.4 billion in Q2 2026, marking the strongest quarter since Q2 2022 and representing a EUR 1.8 billion increase from Q1 2026.
- • Seven mega-transactions exceeding EUR 100 million each drove Q2 performance, including one AI-focused billion-euro deal, indicating concentration of capital among large funding rounds.
- • Scale-up segment companies captured 72% of Q2 capital invested, demonstrating investor preference for businesses in advanced growth phases over early-stage ventures.
- • Healthcare sector dominated deal activity, accounting for one in four transactions in Q2 2026, signaling sustained investor demand for health-focused startups.
- • Deal volume remains below historical averages: only 86 transactions of EUR 1 million or more occurred in Q2, compared to 184 in H1 2026 and 380 for full-year 2025, highlighting consolidation of investment capital among fewer recipients despite record startup formation rates.
Summary
Germany's venture capital market demonstrated significant momentum in the second quarter of 2026, posting its strongest performance in four years. Start-ups raised EUR 3.4 billion during April through June, a substantial increase of EUR 1.8 billion compared to the first quarter's EUR 1.7 billion, according to KfW Research data released on July 20, 2026.
The quarter's exceptional performance was predominantly driven by seven mega-transactions, each exceeding EUR 100 million in value. Among these high-value deals was a notably significant AI-focused investment reaching the billion-euro threshold, underscoring the sector's continued appeal to institutional capital. Dr. Dirk Schumacher, Chief Economist at KfW, stated: "With a volume of 3.4 billion euros, April, May and June were a strong quarter for the German venture capital market," while cautioning that large deals dominate the landscape, noting that "with only 86 transactions of EUR 1 million or more, there is still room for improvement."
Scale-up companies—businesses that have progressed beyond the initial startup phase into strong growth trajectories—captured the lion's share of deployed capital, representing 72% of total Q2 investment volume. This concentration reflects investor preference for mature, high-growth ventures capable of absorbing substantial capital rounds. The healthcare sector demonstrated particular strength, accounting for approximately one in four deals during the quarter, maintaining its position as a high-priority investment category.
Transaction volume metrics reveal an important structural shift in the German VC market. During the first half of 2026, only 184 transactions of EUR 1 million or more were recorded, compared to 380 deals for the entirety of 2025. This decline continues a longer-term trend away from historical peaks—the record of 626 deals was achieved in 2022. Despite annual VC volumes remaining relatively stable at just over EUR 7 billion from 2023 through 2025, the reduction in transaction count indicates that available capital is concentrating among an increasingly smaller number of recipients. This dynamic persists even as new startup formation rates have increased, suggesting a bifurcation between capital accessibility for established growth-stage companies versus earlier-stage ventures.
The quarter's exceptional performance was predominantly driven by seven mega-transactions, each exceeding EUR 100 million in value. Among these high-value deals was a notably significant AI-focused investment reaching the billion-euro threshold, underscoring the sector's continued appeal to institutional capital. Dr. Dirk Schumacher, Chief Economist at KfW, stated: "With a volume of 3.4 billion euros, April, May and June were a strong quarter for the German venture capital market," while cautioning that large deals dominate the landscape, noting that "with only 86 transactions of EUR 1 million or more, there is still room for improvement."
Scale-up companies—businesses that have progressed beyond the initial startup phase into strong growth trajectories—captured the lion's share of deployed capital, representing 72% of total Q2 investment volume. This concentration reflects investor preference for mature, high-growth ventures capable of absorbing substantial capital rounds. The healthcare sector demonstrated particular strength, accounting for approximately one in four deals during the quarter, maintaining its position as a high-priority investment category.
Transaction volume metrics reveal an important structural shift in the German VC market. During the first half of 2026, only 184 transactions of EUR 1 million or more were recorded, compared to 380 deals for the entirety of 2025. This decline continues a longer-term trend away from historical peaks—the record of 626 deals was achieved in 2022. Despite annual VC volumes remaining relatively stable at just over EUR 7 billion from 2023 through 2025, the reduction in transaction count indicates that available capital is concentrating among an increasingly smaller number of recipients. This dynamic persists even as new startup formation rates have increased, suggesting a bifurcation between capital accessibility for established growth-stage companies versus earlier-stage ventures.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.